HCW Biologics Inc. Common Stock
Symbol: HCWB (NASDAQ)
Company Description:
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
- Today's Open: $3.79
- Today's High: $3.79
- Today's Low: $3.775
- Today's Volume: 24
- Yesterday Close: $3.7
- Yesterday High: $3.84
- Yesterday Low: $3.7
- Yesterday Volume: 37.82K
- Last Min Volume: 0
- Last Min High: $3.788
- Last Min Low: $3.775
- Last Min VWAP: $0
- Name: HCW Biologics Inc. Common Stock
- Website: https://www.hcwbiologics.com
- Listed Date: 2021-07-20
- Location: MIRAMAR, FL
- Market Status: Active
- CIK Number: 0001828673
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $7.96M
- Round Lot: 100
- Outstanding Shares: 2.15M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-05 | 8-K | View |
2025-08-19 | 8-K | View |
2025-08-18 | 10-Q | View |
2025-08-18 | 8-K/A | View |
2025-08-15 | NT 10-Q | View |
2025-08-15 | 8-K | View |
2025-08-14 | 8-K | View |
2025-07-18 | 8-K | View |
2025-07-01 | 8-K | View |
2025-06-26 | 8-K | View |
2025-06-23 | 8-K | View |
2025-06-13 | 8-K | View |
2025-06-13 | SCHEDULE 13D/A | View |
2025-06-05 | 8-K | View |
2025-06-04 | 8-K | View |
2025-05-30 | 8-K | View |
2025-05-23 | 8-K | View |
2025-05-20 | 4 | View |
2025-05-20 | 4 | View |
2025-05-20 | 4 | View |